Status:
ENROLLING_BY_INVITATION
Investigating the Minimum Number of Needling Required to Optimize Trigger Point Injections Outcome
Lead Sponsor:
University of Arizona
Conditions:
Myofascial Pain
Myofascial Trigger Point Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Myofascial pain is a common condition in which patients may experience severe chronic pain. The source of this pain is typically the soft tissue. Current methods to address myofascial pain include a p...
Detailed Description
Chronic pain affects over 100 million Americans with an annual cost of about $600 billion/year. Almost half of the chronic pain conditions are attributed to musculoskeletal conditions. Musculoskeleta...
Eligibility Criteria
Inclusion
- Able to speak, read and write English
- Diagnosis of myofascial pain
- Failed conservative therapy or unable to participate in physical therapy
Exclusion
- Serious mental illness that may not enable the patient to perceive pain changes
- History of conditions which may present as diffuse pain
Key Trial Info
Start Date :
April 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 9 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04732507
Start Date
April 20 2021
End Date
December 9 2026
Last Update
January 8 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Banner University Medical Center Multispecialty Services Clinic
Tucson, Arizona, United States, 85711